Cargando…

Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study()

BACKGROUND: Macro- and micro-structural neuroimaging measures provide valuable information on the pathophysiology of Huntington's disease (HD) and are proposed as biomarkers. Despite theoretical advantages of microstructural measures in terms of sensitivity to pathology, there is little evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hobbs, Nicola Z., Cole, James H., Farmer, Ruth E., Rees, Elin M., Crawford, Helen E., Malone, Ian B., Roos, Raymund A.C., Sprengelmeyer, Reiner, Durr, Alexandra, Landwehrmeyer, Bernhard, Scahill, Rachael I., Tabrizi, Sarah J., Frost, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777685/
https://www.ncbi.nlm.nih.gov/pubmed/24179770
http://dx.doi.org/10.1016/j.nicl.2012.12.001
_version_ 1782285001712205824
author Hobbs, Nicola Z.
Cole, James H.
Farmer, Ruth E.
Rees, Elin M.
Crawford, Helen E.
Malone, Ian B.
Roos, Raymund A.C.
Sprengelmeyer, Reiner
Durr, Alexandra
Landwehrmeyer, Bernhard
Scahill, Rachael I.
Tabrizi, Sarah J.
Frost, Chris
author_facet Hobbs, Nicola Z.
Cole, James H.
Farmer, Ruth E.
Rees, Elin M.
Crawford, Helen E.
Malone, Ian B.
Roos, Raymund A.C.
Sprengelmeyer, Reiner
Durr, Alexandra
Landwehrmeyer, Bernhard
Scahill, Rachael I.
Tabrizi, Sarah J.
Frost, Chris
author_sort Hobbs, Nicola Z.
collection PubMed
description BACKGROUND: Macro- and micro-structural neuroimaging measures provide valuable information on the pathophysiology of Huntington's disease (HD) and are proposed as biomarkers. Despite theoretical advantages of microstructural measures in terms of sensitivity to pathology, there is little evidence directly comparing the two. METHODS: 40 controls and 61 early HD subjects underwent 3 T MRI (T1- and diffusion-weighted), as part of the PADDINGTON study. Macrostructural volumetrics were obtained for the whole brain, caudate, putamen, corpus callosum (CC) and ventricles. Microstructural diffusion metrics of fractional anisotropy (FA), mean-, radial- and axial-diffusivity (MD, RD, AD) were computed for white matter (WM), CC, caudate and putamen. Group differences were examined adjusting for age, gender and site. A formal comparison of effect sizes determined which modality and metrics provided a statistically significant advantage over others. RESULTS: Macrostructural measures showed decreased regional and global volume in HD (p < 0.001); except the ventricles which were enlarged (p < 0.01). In HD, FA was increased in the deep grey-matter structures (p < 0.001), and decreased in the WM (CC, p = 0.035; WM, p = 0.053); diffusivity metrics (MD, RD, AD) were increased for all brain regions (p < 0.001). The largest effect sizes were for putamen volume, caudate volume and putamen diffusivity (AD, RD and MD); each was significantly larger than those for all other metrics (p < 0.05). CONCLUSION: The highest performing macro- and micro-structural metrics had similar sensitivity to HD pathology quantified via effect sizes. Region-of-interest may be more important than imaging modality, with deep grey-matter regions outperforming the CC and global measures, for both volume and diffusivity. FA appears to be relatively insensitive to disease effects.
format Online
Article
Text
id pubmed-3777685
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-37776852013-10-31 Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study() Hobbs, Nicola Z. Cole, James H. Farmer, Ruth E. Rees, Elin M. Crawford, Helen E. Malone, Ian B. Roos, Raymund A.C. Sprengelmeyer, Reiner Durr, Alexandra Landwehrmeyer, Bernhard Scahill, Rachael I. Tabrizi, Sarah J. Frost, Chris Neuroimage Clin Article BACKGROUND: Macro- and micro-structural neuroimaging measures provide valuable information on the pathophysiology of Huntington's disease (HD) and are proposed as biomarkers. Despite theoretical advantages of microstructural measures in terms of sensitivity to pathology, there is little evidence directly comparing the two. METHODS: 40 controls and 61 early HD subjects underwent 3 T MRI (T1- and diffusion-weighted), as part of the PADDINGTON study. Macrostructural volumetrics were obtained for the whole brain, caudate, putamen, corpus callosum (CC) and ventricles. Microstructural diffusion metrics of fractional anisotropy (FA), mean-, radial- and axial-diffusivity (MD, RD, AD) were computed for white matter (WM), CC, caudate and putamen. Group differences were examined adjusting for age, gender and site. A formal comparison of effect sizes determined which modality and metrics provided a statistically significant advantage over others. RESULTS: Macrostructural measures showed decreased regional and global volume in HD (p < 0.001); except the ventricles which were enlarged (p < 0.01). In HD, FA was increased in the deep grey-matter structures (p < 0.001), and decreased in the WM (CC, p = 0.035; WM, p = 0.053); diffusivity metrics (MD, RD, AD) were increased for all brain regions (p < 0.001). The largest effect sizes were for putamen volume, caudate volume and putamen diffusivity (AD, RD and MD); each was significantly larger than those for all other metrics (p < 0.05). CONCLUSION: The highest performing macro- and micro-structural metrics had similar sensitivity to HD pathology quantified via effect sizes. Region-of-interest may be more important than imaging modality, with deep grey-matter regions outperforming the CC and global measures, for both volume and diffusivity. FA appears to be relatively insensitive to disease effects. Elsevier 2012-12-09 /pmc/articles/PMC3777685/ /pubmed/24179770 http://dx.doi.org/10.1016/j.nicl.2012.12.001 Text en © 2013 The Authors http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Hobbs, Nicola Z.
Cole, James H.
Farmer, Ruth E.
Rees, Elin M.
Crawford, Helen E.
Malone, Ian B.
Roos, Raymund A.C.
Sprengelmeyer, Reiner
Durr, Alexandra
Landwehrmeyer, Bernhard
Scahill, Rachael I.
Tabrizi, Sarah J.
Frost, Chris
Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study()
title Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study()
title_full Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study()
title_fullStr Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study()
title_full_unstemmed Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study()
title_short Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study()
title_sort evaluation of multi-modal, multi-site neuroimaging measures in huntington's disease: baseline results from the paddington study()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777685/
https://www.ncbi.nlm.nih.gov/pubmed/24179770
http://dx.doi.org/10.1016/j.nicl.2012.12.001
work_keys_str_mv AT hobbsnicolaz evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT colejamesh evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT farmerruthe evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT reeselinm evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT crawfordhelene evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT maloneianb evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT roosraymundac evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT sprengelmeyerreiner evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT durralexandra evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT landwehrmeyerbernhard evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT scahillrachaeli evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT tabrizisarahj evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
AT frostchris evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy